JP5514390B2 - Life extension agent made from cereals and beans other than rice - Google Patents
Life extension agent made from cereals and beans other than rice Download PDFInfo
- Publication number
- JP5514390B2 JP5514390B2 JP2005196003A JP2005196003A JP5514390B2 JP 5514390 B2 JP5514390 B2 JP 5514390B2 JP 2005196003 A JP2005196003 A JP 2005196003A JP 2005196003 A JP2005196003 A JP 2005196003A JP 5514390 B2 JP5514390 B2 JP 5514390B2
- Authority
- JP
- Japan
- Prior art keywords
- added
- water
- product
- beans
- thereafter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title description 18
- 244000046052 Phaseolus vulgaris Species 0.000 title description 18
- 235000013339 cereals Nutrition 0.000 title description 14
- 240000007594 Oryza sativa Species 0.000 title description 12
- 235000007164 Oryza sativa Nutrition 0.000 title description 12
- 235000009566 rice Nutrition 0.000 title description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 230000006872 improvement Effects 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- 210000000963 osteoblast Anatomy 0.000 claims description 4
- 239000000047 product Substances 0.000 description 37
- 108090000790 Enzymes Proteins 0.000 description 33
- 102000004190 Enzymes Human genes 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 19
- 239000002994 raw material Substances 0.000 description 19
- 230000002265 prevention Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 9
- 230000003625 amylolytic effect Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 241000209140 Triticum Species 0.000 description 8
- 235000021307 Triticum Nutrition 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 7
- 240000005979 Hordeum vulgare Species 0.000 description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- -1 facial cleansers Substances 0.000 description 2
- 210000001752 female genitalia Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000000777 hematopoietic system Anatomy 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000005210 lymphoid organ Anatomy 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000000260 male genitalia Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 210000004560 pineal gland Anatomy 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010014190 Eczema asteatotic Diseases 0.000 description 1
- 206010063045 Effusion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000005926 Hamelia patens Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、米を除く穀類及び豆類を原料とする寿命延長剤に関するものである。 The present invention relates to a life extending agent using cereals and beans other than rice as raw materials.
ヒトをはじめとする個体は、誰しも年を取りやがて死を迎えるという現実から回避できない状況下、通常、一年でも長生きすることを切望している。ところで、百薬の長といわれる酒は、適量であれば、人を陽気にさせてストレスを解消させる等、特に精神面に対して好影響を与えることが周知である。そして、ほどほどの酒は、当該ストレス解消を通じて、人を長生きさせると考えられている。ここで、酒の場合は、酒の中に含まれるアルコール(エチルアルコール)が、ストレス解消の有効成分である。
しかしながら、上記のアルコールは、それ自体に直接的に寿命延長効果がある訳ではなく、その効果は間接的である。また、アルコールの酸化物は、有毒であるか又は効果が無いことが確認されている。しかも、継続的なアルコール摂取はアルコール依存症になりやすく、また、過剰のアルコール摂取はアルコール中毒に繋がる可能性もあり、いずれも、むしろ寿命を短縮させる結果となり得る。 However, the above-mentioned alcohol itself does not directly have a life extension effect, and the effect is indirect. Also, it has been confirmed that alcohol oxides are toxic or ineffective. Moreover, continuous alcohol consumption tends to be alcoholic, and excessive alcohol consumption can lead to alcoholism, both of which can rather result in a shortened lifespan.
ところで、本発明者らは、動植物合和すの観点から、主食であり安全性が最も高い白米を中心に様々な研究を進めている。それらの研究の途中で、偶然、当該原料に所定の処理を施したものに顕著な寿命延長効果があることを発見し、当該処理物について既に特許出願をしている(特許文献1参照)。しかし、米を原料として使用すると原価が高くなるという問題がある。 By the way, the present inventors are carrying out various studies focusing on white rice, which is a staple food and has the highest safety, from the viewpoint of combining plants and animals. In the middle of these studies, it was discovered by chance that the raw material that had been subjected to the predetermined treatment had a significant effect of extending the life, and a patent application has already been filed for the treated product (see Patent Document 1). However, there is a problem that the cost increases when rice is used as a raw material.
そこで、本発明者らは、原料・処理条件等様々な角度からの変更を重ねた結果、所定の天然素材に所定処理を施した場合には、寿命延長に有効な成分が産生し得ることを見出し、以下の本発明(1)〜(5)を完成させたものである。 Therefore, as a result of repeated changes from various angles such as raw materials and processing conditions, the present inventors have found that when a predetermined natural material is subjected to a predetermined treatment, an effective component for life extension can be produced. The headline and the following present inventions (1) to (5) are completed.
本発明(1)は、米を除く穀類又は豆類を必須的に含む原料の処理物を有効成分とすることを特徴とする寿命延長剤である。 The present invention (1) is a life extending agent characterized by comprising as an active ingredient a processed product of raw materials essentially containing cereal or beans other than rice.
本発明(2)は、前記処理物が、前記原料の水抽出物又は有機溶媒抽出物である、前記発明(1)の寿命延長剤である。 This invention (2) is a life extension agent of the said invention (1) whose said processed material is the water extract or organic-solvent extract of the said raw material.
本発明(3)は、前記処理物が、前記原料又は前記原料の水抽出物若しくは有機溶媒抽出物の糖化物である、前記発明(1)の寿命延長剤である。 This invention (3) is a life extension agent of the said invention (1) whose said processed material is the saccharified product of the said raw material or the water extract of the said raw material, or an organic solvent extract.
本発明(4)は、前記処理物が、前記原料、前記原料の水抽出物又は有機溶媒抽出物、或いは、前記原料又は前記原料の水抽出物若しくは有機溶媒抽出物の糖化物の、アルコール発酵物又は有機酸発酵物である、前記発明(1)の寿命延長剤である。 In the present invention (4), the treated product is an alcoholic fermentation of the raw material, the water extract or organic solvent extract of the raw material, or the saccharified product of the raw material or the water extract or organic solvent extract of the raw material. It is a life extension agent of the said invention (1) which is a product or an organic acid fermented product.
本発明(5)は、米を除く穀類又は豆類が、小麦、大麦、トウモロコシ又は大豆である、前記発明(1)〜(4)のいずれか一つの寿命延長剤である。 This invention (5) is a life extension agent in any one of said invention (1)-(4) whose cereals or beans except rice are wheat, barley, corn, or soybean.
ここで、本明細書における各用語の意味について説明する。尚、説明の都合上、一部の用語の意味については「発明を実施するための最良の形態」の箇所で述べることとする。 Here, the meaning of each term in this specification is explained. For convenience of explanation, the meaning of some terms will be described in the section “Best Mode for Carrying Out the Invention”.
まず、「水処理物」とは、水を用いた原料の加工品を指し、例えば、原料の水抽出物、水存在下での糖化物(例えば、原料に水を加えて糖化させたもの、原料の水抽出物を糖化させたもの)、水存在下での発酵物(例えば、原料に水を加えて発酵させたもの、原料の水抽出物を発酵させたもの、原料の水抽出物を糖化させたものを発酵させたもの)を包含する。また、ここでの「水」は、水を必須的に含んでいる水性媒体を意味し、例えば、水や水とアルコールとの混合液を含む。 First, “water-treated product” refers to a processed product of a raw material using water, for example, a water extract of the raw material, a saccharified product in the presence of water (for example, saccharified by adding water to the raw material, Saccharified raw water extract), fermented product in the presence of water (for example, fermented by adding water to raw material, fermented raw water extract, raw water extract) Saccharified and fermented). Moreover, "water" here means an aqueous medium that essentially contains water, and includes, for example, water or a mixture of water and alcohol.
「水抽出物」とは、水を用いて、物理的処理(例えば、圧搾、加熱処理)、化学的処理(例えば、酸やアルカリ処理)、生物的(生化学的)処理(例えば、麹、微生物処理、酵素処理)を単独又は組み合わせて施すことをいう。例えば、原料に水を加えたもの、原料を酸又はアルカリで処理したもの、原料の加水物に酵素又は麹を作用させたもの(抽出前又は抽出と同時)、或いは、これらの処理を加熱又は非加熱下でおこなったものである態様を挙げることができる。尚、上記のように「水抽出物」には、糖化酵素や麹を作用させる態様を包含するので、糖化されたものを含むが、当該「糖化されたもの」は、上記の「糖化物」とは別概念である。 “Water extract” refers to physical treatment (eg, pressing, heat treatment), chemical treatment (eg, acid or alkali treatment), biological (biochemical) treatment (eg, straw, (Microbe treatment, enzyme treatment) is applied alone or in combination. For example, water added to raw material, raw material treated with acid or alkali, raw material hydrolyzed with enzyme or koji (before or simultaneously with extraction), or these treatments heated or The aspect which is performed under non-heating can be mentioned. As described above, the “water extract” includes an embodiment in which saccharification enzymes and koji are allowed to act, and thus includes a saccharified product. The “saccharified product” is the above-mentioned “saccharified product”. It is a different concept.
「有機溶媒抽出物」とは、有機溶媒を用いて、例えば、物理的処理(例えば、圧搾、加熱処理)を施すことをいう。 "Organic solvent extract" means performing a physical process (for example, pressing, heat processing) using an organic solvent, for example.
「有効成分として含有する」とは、寿命延長効果を奏する程度に当該成分を含有することを意味し、当該成分が寿命延長剤の一部を構成する場合のみならず、当該成分が寿命延長剤のすべてを構成する場合を含む。 “Contained as an active ingredient” means containing the component to the extent that it has a life extending effect, and not only when the component constitutes a part of the life extending agent, but the component is also a life extending agent. Including all of the above.
「有機酸発酵」とは、例えば、酢酸発酵や乳酸発酵を指す。 “Organic acid fermentation” refers to, for example, acetic acid fermentation or lactic acid fermentation.
「寿命延長剤」とは、投与した場合としない場合とを比較して、細胞、組織、臓器又は個体の寿命が延長される薬剤を意味する。ここで、細胞、組織、臓器又は個体に係る生命体は、多細胞生物(ヒトを含む哺乳類といった高等動物も含む)及び単細胞生物を指す。 “Life extension agent” means an agent that extends the life of a cell, tissue, organ or individual compared to when it is administered or not. Here, the living organisms related to cells, tissues, organs or individuals refer to multicellular organisms (including higher animals such as mammals including humans) and unicellular organisms.
本発明によれば、ヒト等の個体に投与した場合に、細胞の寿命が延長され、細胞から構成される各種細胞群(組織や臓器)の寿命が延長され、ひいては、体全体(個体)の寿命が延長されるという効果を奏する。そして、個体を構成する細胞等に関し、細胞機能、細胞活性、細胞周期、若々しさ、遺伝子機能の正常化をもたらし、更には、個体を構成する器官・臓器・組織・体液に関しても、機能の向上若しくは改善、正常化、健全化、老化防止、若々しさ保持又は若返りをもたらす。更に、これらの結果として、多くの疾病の予防・治癒効果をもたらす。例えば、循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)等の機能の向上又は改善、正常化、健全化、老化防止、若々しさ保持或いは若返り;生命体或いは個体、器官、臓器、組織、体液又は細胞等における疾患及び諸症状の予防、悪化防止、改善、治療;循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)等における疾患及び諸症状の予防、悪化防止、改善、治療;表皮・真皮に起因する皮膚障害、細胞障害、DNA障害、アトピー性皮膚炎、ドライスキン等の乾燥性皮膚症状(アトピー皮膚、乾燥・ソゾウ化皮膚、老化皮膚、魚鱗癬、かさかさ肌、荒れ肌、皮脂欠乏症、乾皮症、乾燥性湿疹、進行性手掌角皮症、紅斑、硬化・角化、亀裂、鱗屑、紋理、痒み、掻瘢痕)、シミ、ソバカス、掻痒症、あせも、荒れ性、しもやけ、ひび、あかぎれ、皮膚老化症状(しわ、ハリ・弾力の低下、たるみ、シミ)、油性肌、ニキビ、色素異常症、紫外線による皮膚障害(シミ、ソバカス)、光炎症、くすみ、黒ずみ、物理・化学的皮膚障害(切り傷、火傷、床ずれ)、水、石けん、洗剤、界面活性剤、溶媒の使用により引き起こされる皮膚症状、皮膚外用剤等の医薬品の副作用、生物的皮膚障害(皮膚感染症)、水虫、皮膚炎、湿疹、創傷治癒、育毛、養毛、発毛、脱毛症の予防、悪化防止、改善、治療;シミ、ソバカス、老人性色素斑の予防、悪化防止、改善、治療;各種炎症、感染症、アレルギー、免疫機能障害、粘膜障害、細胞障害、DNA障害、腫瘍、潰瘍、高脂血症、肥満、糖尿病、動脈硬化、痛風、血圧の健全化、改善(高血圧、低血圧)、ボケ、痴呆症、鼻炎、喘息、目の諸症状、風邪、血管障害、うちみ、肩こり、くじき、神経痛、腰痛、リウマチ、痔、疲労回復、産前産後の冷え症、口内炎、のどの炎症、痛み、咽頭炎、喉頭炎、扁桃炎、歯周炎、歯槽膿漏、歯肉炎、骨粗鬆症、滋養強壮、虚弱体質、肉体疲労、体力低下、塩害防止、ヘリコバクターピロリ生育阻止、ストレス、医薬品による副作用の予防、悪化防止、改善、治療;腫瘍の予防、悪化防止、改善、治療が、癌予防、悪化防止、進行抑制、転移防止、改善、治療;性機能の向上、改善、正常化、健全化又は老化防止、若々しさ保持或いは若返りが期待できる。更に、臓器保存剤や細胞保存剤(培地として使用)としても有用である。 According to the present invention, when administered to an individual such as a human, the lifespan of the cells is extended, and the lifespan of various cell groups (tissues and organs) composed of the cells is extended. There is an effect that the life is extended. In addition, cell functions, cell activity, cell cycle, youthfulness, normalization of gene functions are brought about with respect to cells constituting an individual, and further, functions of organs, organs, tissues, and body fluids constituting an individual are also improved. Improves or improves, normalizes, restores health, prevents aging, maintains youthfulness or rejuvenates. Furthermore, as a result of these, many diseases are prevented and cured. For example, circulatory system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue / organ, spleen, thymus), skin, skin appendages, digestive system (lip, tonsils, teeth, esophagus, stomach) , Small intestine, large intestine, liver, biliary system, spleen), respiratory system (nose, pharynx, larynx, trachea, lung), urinary system (kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine system (Pituitary gland, pineal gland, thyroid gland, adrenal gland), brain, nervous system (peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism), balance / hearing apparatus, visual instrument, each mucous system, motor organ (Bone, joints, muscles, tendons, ligaments) function improvement or improvement, normalization, health, anti-aging, youthfulness retention or rejuvenation; life forms or individuals, organs, organs, tissues, body fluids or cells, etc. Prevention, prevention, improvement, treatment of diseases and symptoms in Japan; cardiovascular system (heart, blood vessel, blood / hematopoietic system), Epidemiological system (lymphoid tissue / organ, spleen, thymus), skin, skin appendages, digestive system (lips, tonsils, teeth, esophagus, stomach, small intestine, large intestine, liver, bile duct, spleen), respiratory system ( (Nose, pharynx, larynx, trachea, lungs), urinary system (kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine system (pituitary gland, pineal gland, thyroid gland, adrenal gland), brain, nervous system (Peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism), balance / auditor, visual organ, each mucosal system, motor organs (bone, joint, muscle, tendon, ligament), etc. and various symptoms Prevention, deterioration prevention, improvement, treatment of skin; skin disorders caused by epidermis / dermis, cell disorders, DNA disorders, atopic dermatitis, dry skin symptoms such as dry skin (atopy skin, dry / sozoized skin, aging skin) , Ichthyosis, bulky skin, rough skin, sebum deficiency, xeroderma, dry eczema, progressive Palmokeratosis, erythema, sclerosis / keratinization, cracks, scales, crests, itching, scarring), spots, buckwheat, pruritus, skin rash, roughness, moistness, cracks, redheads, skin aging symptoms (wrinkles, tension, elasticity Reduction, sagging, stains), oily skin, acne, dyschromia, UV-induced skin damage (stains, freckles), photoinflammation, dullness, darkening, physical / chemical skin disorders (cuts, burns, bedsores), water, Skin symptoms caused by the use of soaps, detergents, surfactants, solvents, side effects of pharmaceuticals such as topical skin preparations, biological skin disorders (skin infections), athlete's foot, dermatitis, eczema, wound healing, hair growth, hair restoration Prevention, deterioration prevention, improvement, treatment of hair growth, alopecia; prevention, prevention, improvement, treatment of spots, buckwheat, senile pigment spots; various inflammations, infections, allergies, immune dysfunction, mucosal disorders, cells Disorder, DNA disorder , Tumor, ulcer, hyperlipidemia, obesity, diabetes, arteriosclerosis, gout, blood pressure restoration, improvement (high blood pressure, hypotension), blur, dementia, rhinitis, asthma, various symptoms of the eye, cold, vascular disorder , Internal stiffness, shoulder stiffness, lottery, neuralgia, low back pain, rheumatism, hemorrhoids, recovery from fatigue, prenatal birth cold, stomatitis, throat inflammation, pain, pharyngitis, laryngitis, tonsillitis, periodontitis, alveolar pus effusion, gingivitis , Osteoporosis, nourishing tonic, weak constitution, physical fatigue, physical strength reduction, salt damage prevention, Helicobacter pylori growth inhibition, stress, prevention of side effects caused by drugs, prevention, improvement, treatment; tumor prevention, prevention of deterioration, improvement, treatment, Cancer prevention, deterioration prevention, progression inhibition, metastasis prevention, improvement, treatment; sexual function improvement, improvement, normalization, restoration or prevention of aging, youthfulness retention or rejuvenation can be expected. Furthermore, it is also useful as an organ preservative or cell preservative (used as a medium).
本発明に係る「米を除く穀物又は豆類」とは、例えば、米を除く小麦、大麦、とうもろこし、ひえ、あわ、そば、ライ麦等であり、豆類とは、大豆、えんどう豆、いんげん豆、小豆、そら豆等を挙げることができる。また、豆の状態は、未熟生豆、完熟生豆、さらに、乾燥処理した完熟豆等どんなものでもよい。 The “cereal or beans other than rice” according to the present invention is, for example, wheat, barley, corn, rice, wax, buckwheat, rye, etc., excluding rice, and beans are soybeans, peas, beans, red beans, etc. And broad beans. Further, the beans may be in any state such as immature raw beans, fully-ripe raw beans, and dry-processed fully-ripe beans.
穀物、豆類を水抽出物又は有機溶媒抽出する場合、まず、穀物、豆類を粉砕又は粉体化すると表面積が大きくなるため、極めて抽出効率が良好になる。この方法は、粉砕機等を用い、一般的な方法によればよい。粉砕しなくてもよいが、この場合には、穀物組織、豆組織の分解及び抽出に長時間を要する。 When cereals and beans are extracted with a water extract or an organic solvent, first, when the cereals and beans are ground or pulverized, the surface area becomes large, and thus the extraction efficiency is extremely good. This method may be a general method using a pulverizer or the like. Although it is not necessary to grind, in this case, it takes a long time to decompose and extract the grain structure and the bean structure.
水抽出に当たっては、穀物、豆をそのまま、好ましくは粉砕又は粉体化したものに加水する。穀物は玄穀でも精白穀でもよい。加水量については、穀物、豆に対して2〜5倍量で効率よく抽出されるが、収率、作業性、最終使用目的等に応じて適宜選定すればよい。この後加温してゆき、沸騰状態になった時点で抽出を完了する。抽出を完了した後、使用目的により圧搾、濾過を行えば、清澄な抽出エキスが得られる。なお、最初から熱水を加えて抽出を行ってもよい。 In the water extraction, cereals and beans are added as they are, preferably pulverized or powdered. The cereal may be brown or refined. The amount of water added can be efficiently extracted in an amount 2 to 5 times that of cereals and beans, but may be appropriately selected according to the yield, workability, end use purpose, and the like. After this, the mixture is heated and the extraction is completed when it reaches a boiling state. After completion of the extraction, a clear extract can be obtained by pressing and filtering according to the purpose of use. In addition, you may extract by adding hot water from the beginning.
抽出液中の有効成分は解明されていないが、この未知の有効成分が熱に安定であることは確認できたので、水抽出の際の抽出温度は、高温が効率的である。低温でも長時間置けば、充分に抽出を行うことができる。ただし、40℃以下の低温の場合は、pHを酸性あるいはアルカリ性にするか、防腐剤を加えることが好適である。抽出時間は、沸騰抽出の場合には数分でよいが、それ以下の中温の場合には、数時間から一昼夜が必要である。低温の場合は、穀物、豆の粉砕状態にもよるが、数日〜1ケ月必要である。ただし、この場合にも、なるべく最後には加熱するのがより効果的である。 Although the active ingredient in the extract has not been elucidated, it has been confirmed that this unknown active ingredient is stable to heat, so that the extraction temperature at the time of water extraction is efficient. Extraction can be carried out sufficiently by placing it at a low temperature for a long time. However, in the case of a low temperature of 40 ° C. or lower, it is preferable to make the pH acidic or alkaline, or to add a preservative. In the case of boiling extraction, the extraction time may be several minutes, but in the case of a medium temperature lower than that, several hours to one day are required. In the case of low temperature, it takes several days to one month depending on the pulverized state of grains and beans. However, even in this case, it is more effective to heat at the end as much as possible.
水抽出の場合に最も問題になるのは、糊化現象である。糊状になれば抽出効率が悪くなるのみでなく、実作業においては困難を極める。これを防ぐためには、アミラーゼを加えて反応させるか、塩酸などで酸性にして澱粉を分解すればよく、この方法を用いることにより、充分に解決でき、実用上も全く問題がない。 The most serious problem in the case of water extraction is the gelatinization phenomenon. If it becomes paste-like, not only extraction efficiency will worsen but it will be extremely difficult in actual work. In order to prevent this, starch may be decomposed by adding amylase to react or acidifying with hydrochloric acid or the like. By using this method, the problem can be solved sufficiently and there is no problem in practical use.
抽出液中の有効成分は、酸、アルカリに安定であるためか、酸抽出あるいはアルカリ抽出物を行うのも有効である。更に、水抽出の場合、穀物、豆の組織に働く酵素(例えば、セルラーゼ)を作用させてもよい。ここでいう酵素とは、澱粉分解酵素(液化酵素、糖化酵素)、蛋白分解酵素、脂肪分解酵素、繊維分解酵素、リグニン分解酵素、ペクチン分解酵素の1種又は2種以上の組み合わせである。尚、抽出を行うに際し、酵素を作用させるタイミングは、抽出の前又は抽出と同時のいずれでもよい。 It is also effective to perform acid extraction or alkali extraction because the active ingredient in the extract is stable to acid and alkali. Furthermore, in the case of water extraction, an enzyme (for example, cellulase) that acts on the grain or bean tissue may be allowed to act. The enzyme here is one or a combination of two or more of amylolytic enzymes (liquefaction enzymes, saccharifying enzymes), proteolytic enzymes, lipolytic enzymes, fiber-degrading enzymes, lignin-degrading enzymes, and pectin-degrading enzymes. In addition, when performing extraction, the timing which acts an enzyme may be either before extraction or simultaneously with extraction.
更に、有機溶媒抽出でも、本効果をもったエキスが抽出されることが判明した。このことは、有効成分の解明を進める上で、また、有効成分を濃厚に抽出したり、水に溶けないものとの配合という利用用途の上で極めて有効である。この場合、なるべく微粉砕又は粉体化することが好ましい。また、ここで用いる有機溶媒はアルコールのような人体に投与しても安全なものを使用することが望ましい。 Furthermore, it has been found that an extract having this effect can also be extracted by organic solvent extraction. This is extremely effective in elucidating the active ingredient, and in use such as extracting the active ingredient in a concentrated manner or blending with an ingredient that is insoluble in water. In this case, it is preferable to pulverize or powder as much as possible. In addition, it is desirable to use an organic solvent that is safe to administer to the human body such as alcohol.
また、とうもろこしのような生鮮穀類(加熱滅菌したものを含む)、生豆(加熱処理したものを含む)の場合、水や有機溶媒を用いず、試料を布か圧搾機で搾ったもの(搾汁)であってもよい。更に、圧搾をした後の残渣を水抽出又は有機溶媒抽出したものであってもよい。 In addition, in the case of fresh cereals such as corn (including those that have been heat-sterilized) and green beans (including those that have been heat-treated), the sample is squeezed with a cloth or a press without using water or an organic solvent (squeezed) Juice). Furthermore, the residue after pressing may be extracted with water or an organic solvent.
さらに、アルコール発酵、乳酸発酵や酢酸発酵等の有機酸発酵を組み合わせてもよい。 Furthermore, you may combine organic acid fermentation, such as alcohol fermentation, lactic acid fermentation, and acetic acid fermentation.
また、用途によっては搾汁や水抽出物に糖やデキストリンが含まれてベタつくとか、その効果において邪魔になる場合がある。その場合には、デキストリンはアミラーゼで糖化した後、糖を酵母に食べさせるとか、有効成分を吸着剤で分画するとか、有機溶媒で抽出することにより糖を除いてやればよい。いずれにしても、抽出さえ行えば効果が出てくるわけで、用途によっては不要の成分は種々の方法により取り除けばよい。 In addition, depending on the application, sugar or dextrin may be included in the juice or water extract, or it may become an obstacle in its effect. In that case, after dextrin is saccharified with amylase, the sugar may be removed by feeding the sugar to yeast, fractionating the active ingredient with an adsorbent, or extracting with an organic solvent. In any case, an effect can be obtained by performing extraction, and unnecessary components may be removed by various methods depending on applications.
以上のようにして得られた本発明に係る寿命延長剤は、残渣と分離することなくそのままの状態で、或いは、圧搾や濾過を行った後、対象物(細胞、組織、臓器又は個体)に適用する。ここで、そのまま用いるときは、殺菌或いは除菌を行うことが好適である。本発明に係る寿命延長剤は、例えば個体に適用する場合、内用でも外用でもよい。具体的には、実際の用途に応じ、常法にしたがってクリーム、洗顔料、乳液、化粧水、クレンジング、パック、石鹸等の化粧料、軟膏剤、パスタ剤、ローション剤、チンキ剤、リエメント剤、ゼリー剤、エアゾール剤、液剤、ゼリー剤、エリキシル剤、カプセル剤(軟カプセル剤、硬カプセル剤)、顆粒剤、丸剤、懸濁剤、乳剤、散剤、細粒剤、錠剤、シロップ剤、注射剤、トローチ剤、リモナーデ剤等の経口剤、注射剤等の剤型で用いる。更には、食品や飲料に添加する処方もあり得る。尚、用途に応じ、他の配合成分や薬剤を添加してもよい。ヒトに投与する場合の投与量は、使用者の年齢、体重や重篤度等にもよるが、一般的に、製品100重量部当たり、本発明品エキスを0.0001〜90重量部、好適には0.01〜60重量部、最も好適には0.1〜30重量部添加する。また、本発明品の摂取量は、体重1kg当たり、一日0.0001〜100ml、好適には一日0.001〜50ml、最も好適には0.01〜20mlである。 The life extension agent according to the present invention obtained as described above is applied to an object (cell, tissue, organ or individual) as it is without being separated from the residue or after being squeezed or filtered. Apply. Here, when used as it is, it is preferable to perform sterilization or sterilization. The life extension agent according to the present invention may be used internally or externally, for example, when applied to an individual. Specifically, according to the actual application, according to conventional methods, cosmetics such as creams, facial cleansers, emulsions, lotions, cleansings, packs, soaps, ointments, pasta agents, lotions, tinctures, ligaments, Jelly, aerosol, liquid, jelly, elixir, capsule (soft capsule, hard capsule), granule, pill, suspension, emulsion, powder, fine granule, tablet, syrup, injection It is used in oral dosage forms such as pills, troches and limonades, and in dosage forms such as injections. Furthermore, there may be a prescription added to foods and beverages. In addition, you may add another compounding component and a chemical | medical agent according to a use. The dosage when administered to humans depends on the age, body weight, severity, etc. of the user, but generally 0.0001-90 parts by weight of the extract of the present invention per 100 parts by weight of the product is preferable. Is added in an amount of 0.01 to 60 parts by weight, most preferably 0.1 to 30 parts by weight. The intake of the product of the present invention is 0.0001 to 100 ml per day, preferably 0.001 to 50 ml, most preferably 0.01 to 20 ml per kg body weight.
尚、実際の製品との関係では、例えば、寿命延長のために用いられるものである旨の表示を製品(例えば、薬剤、化粧品、飲食品)のパッケージ、パンフレット及び取扱説明書等に付した態様が好適である。このような表示を付することにより、本発明品がそのような効果を奏することが、ユーザに一目瞭然となる。加えて、他の法律(薬事法)の制限により、製品等に直接表示できない場合には、例えば、新聞記事等の形で当該製品の効能をユーザに間接的に告知する手法や、営業が口頭で当該効能をユーザに告知する手法も想定される。したがって、「寿命延長のために用いられるものである旨の表示」には、これらの手法も含め、寿命延長を製品に直接明記した場合や示唆する表示のみならず、間接的に表示又は告知する行為も包含される。また、寿命延長効果としては、少なくとも試験例で示した結果の10%程度以上奏することが好適であり、50%程度奏することがより好適であり、80%程度奏することが最も好適である。 In relation to the actual product, for example, an indication that the product is used for extending the life of the product, such as a drug, a cosmetic, a food and drink package, a pamphlet, and an instruction manual. Is preferred. By attaching such a display, it is obvious to the user that the product of the present invention has such an effect. In addition, when it cannot be displayed directly on a product due to restrictions of other laws (pharmaceutical law), for example, a method of indirectly informing the user of the effectiveness of the product in the form of newspaper articles, etc. A method of notifying the user of the effect is also assumed. Therefore, the “indication that the product is used for extending the life” includes not only the indication or suggestion of the extension of the life directly on the product but also the indication or announcement indirectly including these methods. Actions are also included. Moreover, as a life extension effect, it is preferable to play at least about 10% of the results shown in the test examples, more preferably about 50%, and most preferably about 80%.
製造例1(小麦の抽出物)
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品25Lと残渣13kgを得た。
Production Example 1 (Wheat extract)
10 kg of wheat was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Then, it was squeezed with a squeezing machine to obtain 25 L of this example product and 13 kg of residue.
実施例2(大麦の抽出物)
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品25Lと残渣13kgを得た。
Example 2 (Barley extract)
10 kg of barley was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Then, it was squeezed with a squeezing machine to obtain 25 L of this example product and 13 kg of residue.
製造例3(とうもろこしの抽出物)
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品12Lと残渣26kgを得た。
Production Example 3 (corn extract)
10 kg of corn was pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, the product was squeezed with a squeezing machine to obtain 12 L of this example product and 26 kg of residue.
製造例4(大豆の抽出物)
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品6Lと残渣30kgを得た。
Production Example 4 (Soybean extract)
10 kg of soybeans were pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, the product was squeezed with a squeezing machine to obtain 6 L of this example and 30 kg of residue.
製造例5(小麦の糖化物)
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 5 (Saccharified wheat)
10 kg of wheat was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 26 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
実施例6(大麦の糖化物)
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
Example 6 (Saccharified barley)
10 kg of barley was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 26 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
製造例7(とうもろこしの糖化物)
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液15Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 7 (Saccharified corn)
10 kg of corn was pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 15 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
製造例8(大豆の糖化物)
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液8Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 8 (Saccharified soybean)
10 kg of soybeans were pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 8 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
製造例9(小麦の発酵物)
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 9 (fermented wheat)
10 kg of wheat was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. After cooling, yeast was added and fermentation was performed for 15 days. Thereafter, solid-liquid separation was performed using a filter to obtain 26 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
実施例10(大麦の発酵物)
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
Example 10 (fermented barley)
10 kg of barley was pulverized well, and 30 L of warm water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. After cooling, yeast was added and fermentation was performed for 15 days. Thereafter, solid-liquid separation was performed using a filter to obtain 26 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
製造例11(とうもろこしの発酵物)
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液15Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 11 (fermented corn)
10 kg of corn was pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. After cooling, yeast was added and fermentation was performed for 15 days. Thereafter, solid-liquid separation was performed using a filter to obtain 15 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
製造例12(大豆の発酵物)
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液8Lを得た。これを85℃で30分加熱して本例品を得た。
Production Example 12 (fermented soybean)
10 kg of soybeans were pulverized well, 30 L of hot water at 60 ° C. and 50 g of liquefied enzyme were added thereto and stirred well. Thereafter, the temperature was gradually raised, boiled and extracted for 5 minutes, and then cooled to 30 ° C. Thereafter, 50 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. After cooling, yeast was added and fermentation was performed for 15 days. Thereafter, solid-liquid separation was performed using a filter to obtain 8 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain this example product.
試験例(細胞の寿命延長試験)
・使用細胞:骨芽細胞(mouse Osteoblast MC3T3-E1)
・使用培地:DMEM
・使用試料:製造例11
6wellマイクロプレートに10%濃度で骨芽細胞を播種し、細胞が接着するまで37℃、5%CO2下前培養をおこなった。翌日細胞が接着している事を確認し、培地に対して所定濃度(5%)となるように試料を添加した。そして、37℃、5%CO2存在下で培養を行った。数日以内にコンフレントになることを確認し、27日後の細胞の様子を目視で評価を行った。なお、比較のため、水のみを添加した場合と、本発明者が既に出願した米エキス(特許文献1参照)を添加した場合も同様に試験した。その結果を図1に示す。ここで、図1(a)は水のみを添加した場合の写真、図1(b)は製造例11を添加した場合の写真、図1(c)は米エキスを添加した場合の写真である。図より明らかなように、製造例11を添加した場合には、水と比較して細胞の状態が顕著に良好であることが判明した。加えて、製造例11を添加した場合は、米エキスを添加した場合と比較して遜色ないことも判明した。尚、結果は明記しないが他の製造例についても同様の結果を得た。
Test example (cell life extension test)
・ Used cells: Osteoblast (mouse Osteoblast MC3T3-E1)
-Medium used: DMEM
Sample used: Production Example 11
Osteoblasts were seeded in a 6-well microplate at a concentration of 10%, and precultured at 37 ° C. and 5% CO 2 until the cells adhered. On the next day, it was confirmed that the cells were adhered, and the sample was added to a predetermined concentration (5%) with respect to the medium. The culture was performed at 37 ° C. in the presence of 5% CO 2 . It was confirmed that the cells became confluent within a few days, and the appearance of the cells after 27 days was visually evaluated. For comparison, the same test was performed when only water was added and when the rice extract already filed by the present inventor (see Patent Document 1) was added. The result is shown in FIG. Here, FIG. 1 (a) is a photograph when only water is added, FIG. 1 (b) is a photograph when Production Example 11 is added, and FIG. 1 (c) is a photograph when rice extract is added. . As is clear from the figure, it was found that when Production Example 11 was added, the state of the cells was significantly better than that of water. In addition, it was also found that the case where Production Example 11 was added was comparable to the case where rice extract was added. Although the results are not specified, similar results were obtained for other production examples.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005196003A JP5514390B2 (en) | 2005-07-05 | 2005-07-05 | Life extension agent made from cereals and beans other than rice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005196003A JP5514390B2 (en) | 2005-07-05 | 2005-07-05 | Life extension agent made from cereals and beans other than rice |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007015941A JP2007015941A (en) | 2007-01-25 |
JP5514390B2 true JP5514390B2 (en) | 2014-06-04 |
Family
ID=37753417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005196003A Active JP5514390B2 (en) | 2005-07-05 | 2005-07-05 | Life extension agent made from cereals and beans other than rice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5514390B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5307019B2 (en) * | 2007-09-27 | 2013-10-02 | サッポロビール株式会社 | Bone resorption inhibitor and beverages, foods and pharmaceuticals containing the same |
JP2011057642A (en) * | 2009-09-14 | 2011-03-24 | National Agriculture & Food Research Organization | Neurite outgrowth promoter |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05310589A (en) * | 1992-05-15 | 1993-11-22 | Soken Kk | Active oxygen elimination agent prepared from cereal |
JPH05310590A (en) * | 1992-05-15 | 1993-11-22 | Soken Kk | Active oxygen elimination agent |
JPH05320061A (en) * | 1992-05-19 | 1993-12-03 | Soken Kk | Active oxygen-eliminating agent produced from bean |
-
2005
- 2005-07-05 JP JP2005196003A patent/JP5514390B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2007015941A (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106794202B (en) | Improve the composition of human skin health and its prepares the purposes in product | |
CN101048166A (en) | Abnormal protein removing composition | |
TWI516280B (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
CN105054076B (en) | A kind of alimentation composition and its application for helping to improve alzheimer's disease | |
JPH05139984A (en) | Active oxygen eliminant from rice | |
CN105596277A (en) | Cactus face cream for treating acne and preparation method thereof | |
CN105451712B (en) | Be used to prepare with the reaction platform of the substance based on pollen of beeswax combination and method and application thereof | |
KR20100028258A (en) | Method for preparing functional natural fermentation condiment and sea-tangle fermentation powder containing gaba using fermentation of sea-tangle | |
CN1735420A (en) | Indian herbal soft drink | |
EP2330926A2 (en) | Therapeutic and nutritional food product and soup | |
JP5514390B2 (en) | Life extension agent made from cereals and beans other than rice | |
CN102125196A (en) | Bee product formulation | |
JPH0977674A (en) | Medicinal dry yeast-containing functional composition | |
JP2009143886A (en) | Growth hormone secretagogue | |
KR101063544B1 (en) | Cosmetic composition and preparation method thereof | |
JP6133471B2 (en) | Xanthine oxidase inhibitor | |
CN110075280A (en) | A kind of compound oral agents of laminin peptide and preparation method thereof | |
CN110915970A (en) | Traditional Chinese medicine tablet candy capable of reducing urate deposition and preparation method thereof | |
CN116076710A (en) | Rose herbal ferment with anti-aging and whitening functions and preparation method and application thereof | |
JP5307969B2 (en) | Life extension agent containing white rice-derived ingredients as active ingredients | |
CN105331477A (en) | White grape wine and preparation method thereof | |
CN106176510A (en) | A kind of oral thing for aesthetic health care and corresponding beautifying health composition | |
JP2021529183A (en) | Composition for diabetes improvement or antioxidant containing yeast extract and method for producing yeast extract | |
JP5296957B2 (en) | Anti-aging agent for oral use | |
CN104013853B (en) | A kind of composition of strong kidney kidney tonifying and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080617 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110920 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111117 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120313 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120411 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20120601 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140331 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5514390 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |